■ 学術雑誌
|
原著
|
|
1.
|
中西 健太郎, 吉岡 弘鎮, 奥野 祐希子, 上硲 敬介, 竹安 優貴, 勝島 詩恵, 山中 雄太, 中村 聡明, 畑地 治, 倉田 宝保：
長期生存時代において脳転移を有する再発非小細胞肺癌の定位放射線治療による晩期障害として放射線脳壊死を来した1例.
肺癌
65
(2)
：113
-119
, 2025
|
|
2.
|
池田慧、清家正博、小澤雄一、花田満美、長谷川一男、川崎由華、伊藤ゆり、池田徳彦：
患者・医師アンケート2023から見えてくる、肺がん治療と仕事の両立支援のいま.
肺癌
65
(2)
：80
-90
, 2025
|
|
3.
|
Felip E, Rojas CI, Schenker M, Kowalski DM, Casarini IA, Csöszi T, Şendur
MAN, Martins J, Blanco AC, Wang CC, Song X, Ramirez Fallas RAL, Yoshioka H, Nair
S, Wang M, Deng X, Lala M, Eiras R, Takahashi T.：
Subcutaneous Versus Intravenous Pembrolizumab, in Combination With Chemotherapy, for Treatment of Metastatic Non-Small Cell Lung Cancer: The Phase 3 3475A-D77 Trial.
Annals of oncology
36
(7)
：775
-785
, 2025
|
|
4.
|
Takashi Nojiri, Akiisa Omura, Kiyotsugu Iede, Utae Katsushima, Masahiko Higashiyama：
Clinical Impact of Upfront Dose Reduction of the First Cycle of First-Line Treatments on Safety and Survival in Elderly Patients With Non-Small Cell Lung Cancer.
Asia-Pacific journal of clinical oncology
：Online ahead of print
, 2025
|
|
5.
|
Nishioka N, Hata T, Yamada T, Goto Y, Amano A, Negi Y, Watanabe S, Furuya N,
Oba T, Ikoma T, Nakao A, Tanimura K, Taniguchi H, Yoshimura A, Fukui T, Murata
D, Kaira K, Shiotsu S, Hibino M, Okada A, Chihara Y, Kawachi H, Kijima T,
Takayama K.：
Impact of TTF-1 Expression on the Prognostic Prediction of Patients with Non-Small Cell Lung Cancer with PD-L1 Expression Levels of 1% to 49%, Treated with Chemotherapy vs. Chemoimmunotherapy: A Multicenter, Retrospective Study.
Cancer research and treatment
57
(2)
：412
-421
, 2025
|
|
6.
|
Kanda S, Niho S, Kurata T, Nomura S, Kawashima Y, Iwama E, Yokoyama T,
Watanabe Y, Tanaka H, Fujiwara Y, Zenke Y, Azuma K, Taniguchi H, Toyozawa R,
Hosomi Y, Murakami H, Hara S, Bessho A, Yamamoto N, Ohe Y.：
Randomized Phase III Study of EGFR Tyrosine Kinase Inhibitor and Intercalated Platinum-doublet Chemotherapy for Non-small Cell Lung Cancer Harboring EGFR Mutation.
Clinical cancer research
31
(12)
：2317
-2326
, 2025
|
|
7.
|
Hata T, Yamada T, Goto Y, Amano A, Negi Y, Watanabe S, Furuya N, Oba T, Ikoma
T, Nakao A, Tanimura K, Taniguchi H, Yoshimura A, Fukui T, Murata D, Kaira K,
Shiotsu S, Hibino M, Okada A, Chihara Y, Kawachi H, Kijima T, Takayama K.：
Regimen Selection for Chemoimmunotherapy in Nonsquamous Non-Small Cell Lung Cancer with Low PD-L1 Expression: A Multicenter Retrospective Cohort Study.
Clinical lung cancer
26
(3)
：e190
-e198.e4
, 2025
|
|
8.
|
Y Shiraishi, T Shimose, Y Tsuchiya-Kawano, H Ishii, K Mizuno, Y Toi, H Daga, K Ito, S Iyama, H Taniguchi, R Morinaga, T Harada, H Inoue, Y Misumi, K Naoki, K Tobino, M Izumi, S Omori, S Tsumura, Y Yamanaka, Y Sakata, S Miura, H Mizutani, M Oki, E Iwama, K Otsubo, I Okamoto：
Platinum plus etoposide with durvalumab for extensive-stage small-cell lung cancer with untreated brain metastases: a multicenter, single-arm phase II trial (LOGiK2001, SPEED).
ESMO open
10
(7)
：105325
, 2025
|
|
9.
|
Norifumi Tsubokawa, Yasuhiro Tsutani, Tomoyuki Hishida, Hisashi Saji, Masashi Wakabayashi, Makoto Endo, Takahiro Mimae, Tomohiro Miyoshi, Tetsuya Isaka, Mitsuhiro Isaka, Aritoshi Hattori, Hiroshige Yoshioka, Ryu Nakajima, Masaya Yotsukura, Tomohiro Maniwa, Yuta Sekino, Haruhiko Fukuda, Kazuo Nakagawa, Keiju Aokage, Shun-Ichi Watanabe, Morihito Okada：
Quality comparison of mediastinal lymph node dissection between video-assisted thoracic surgery and open thoracotomy: a supplementary analysis of the phase 3 Japan Clinical Oncology Group 1413 trial.
European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery
67
(7)
：ezaf206
, 2025
|
|
10.
|
Ishida Y, Ikeda S, Harada T, Sakakibara-Konishi J, Yokoo K, Kikuchi H, Iwasawa T, Misumi T, Konno S, Ogura T.：
High incidence of immune checkpoint inhibitor-induced pneumonitis in patients with non-small cell lung cancer and interstitial pneumonia, regardless of honeycomb lung or forced vital capacity: results from a multicenter retrospective study.
International Journal of Clinical Oncology
：Online ahead of print
, 2025
|
|
11.
|
Hidenobu Ishii, Koichi Azuma, Yuta Yamanaka, Hiroshige Yoshioka, Yukihiro Toi, Naoki Shingu, Katsuhiko Naoki, Masaki Okamoto, Yuko Tsuchiya-Kawano, Taishi Harada, Hiroyuki Inoue, Hiroshi Ishii, Kazunori Tobino, Chiho Nakashima, Yoshifusa Koreeda, Yasushi Hisamatsu, Shinsuke Tsumura, Takashi Inagaki, Keiko Mizuno, Takayuki Shimose, Isamu Okamoto：
Turtle Study: A Phase 2 Study of Durvalumab Plus Carboplatin and Etoposide in Elderly Patients With Extensive-Stage SCLC (LOGiK 2003).
JTO clinical and research reports
6
(7)
：100836
, 2025
|
|
12.
|
Katsushima U, Kurose S, Fukushima T, Nakano J, Ogushi N, Fujii K, Nagata Y,
Kamisako K, Okuno Y, Okazaki Y, Nakanishi K, Yoshida K, Ikoma T, Takeyasu Y,
Yamanaka Y, Yoshioka H, Hase K, Kurata T.：
Impact of time to treatment initiation on the development of cachexia and clinical outcomes in lung cancer.
Japanese journal of clinical oncology
55
(5)
：505
-513
, 2025
|
|
13.
|
Miura S, Tanaka H, Misumi T, Yoshioka H, Tokito T, Fukuhara T, Sato Y,
Shiraishi Y, Naoki K, Akamatsu H, Yamaguchi O, Yokoyama T, Kuyama S, Nishino K,
Furuya N, Kurata T, Kato T, Ikeda S, Horinouchi H, Ichihara E, Mori M, Takiguchi
Y, Tanaka K, Goto Y, Okamoto H; Thoracic Oncology Research Group and all
ACHILLES investigators.：
Pragmatic Randomized Study of Afatinib Versus Chemotherapy for Patients With Non-Small Cell Lung Cancer With Uncommon Epidermal Growth Factor Receptor Mutations: ACHILLES/TORG1834.
Journal of clinical oncology
43
(18)
：2049
-2058
, 2025
|
|
14.
|
Fukui T, Mamesaya N, Takahashi T, Kishi K, Yoshizawa T, Tokito T, Azuma K,
Morikawa K, Igawa S, Okuma Y, Yamanaka Y, Hosokawa S, Kasai T, Masubuchi K,
Nakamichi S, Aga M, Sasaki J, Kada A, Saito AM, Naoki K, Okamoto H; Thoracic
Oncology Research Group (TORG).：
A Prospective Phase II Trial of First-line Osimertinib for Patients with EGFR Mutation-positive Non-small Cell Lung Cancer and Poor Performance Status (OPEN/TORG2040).
Journal of thoracic oncology
20
(5)
：665
-675
, 2025
|
|
15.
|
Akamatsu H, Sakata S, Azuma K, Yoshioka H, Uemura T, Tsuchiya-Kawano Y, Esumi
S, Kurosaki T, Sato Y, Sakamoto T, Ninomiya K, Toyozawa R, Yoneshima Y, Shukuya
T, Kozuki T, Watanabe K, Daga H, Kato T, Takahashi T, Osuga M, Koh Y, Morita S,
Yamamoto N.：
A Single-Arm Phase 2 Study of Sotorasib Plus Carboplatin and Pemetrexed in Patients With Advanced Nonsquamous NSCLC With KRAS G12C Mutation (WJOG14821L, SCARLET).
Journal of thoracic oncology
20
(6)
：775
-785
, 2025
|
|
16.
|
Ikeda S, Ogura T, Miyaoka E, Sekine I, Shukuya T, Takayama K, Inoue A, Okamoto I, Seike M, Takahashi K, Yamamoto N, Yotsukura M, Watanabe S, Shintani Y.：
Survival Benefit and Potential Markers of Chemotherapy for Elderly and Poor Performance Status Patients with Advanced Non-Small Cell Lung Cancer: Results from the Japanese Joint Committee of Lung Cancer Registry Database.
Lung Cancer
200
：108102
, 2025
|
|
17.
|
Tachihara M, Shoda H, Akazawa Y, Ota T, Oki M, Sato Y, Sugawara S, Ikeda S, Yokoyama T, Kaneda H, Itoh S, Bessho A, Katakami N, Morita S, Nakagawa K, Okamoto I, Yamamoto N.：
Durvalumab plus irinotecan + cisplatin for untreated extensive-stage small cell lung cancer: REBORN, phase II study (WJOG13520L).
Lung Cancer
Epub ahead of print
, 2025
|
|
18.
|
Byoung Chul Cho, Hidetoshi Hayashi, Jong-Seok Lee, Se-Hoon Lee, Pongwut Danchaivijitr, Ying Cheng, Baogang Liu, Adlinda Alip, Hailin Xiong, Soon Hin How, Gee-Chen Chang, James Chih-Hsin Yang, Hiroshige Yoshioka, Mehmet Ali Nahit Şendur, Kumar Prabhash, Koichi Azuma, Yun-Gyoo Lee, Chien-Chung Lin, Shingo Matsumoto, Patrapim Sunpaweravong, Yichuan Xia, Melissa Martinez, Joshua M Bauml, Seema Sethi, Shun Lu：
Amivantamab plus lazertinib versus osimertinib as first-line treatment in EGFR-mutated advanced non-small cell lung cancer: MARIPOSA Asian subset.
Lung cancer (Amsterdam, Netherlands)
204
：108496
, 2025
|
|
19.
|
Shogo Nomura, Yuta Sekino, Yoshimasa Shiraishi, Yukihiro Toi, Tatsuya Yoshida, Kentaro Tanaka, Shinichiro Suzuki, Koichi Azuma, Satoshi Hara, Ryo Morita, Seiji Niho, Takuyuki Koda, Ryo Toyozawa, Kiyotaka Yoh, Takayasu Kurata, Haruhiko Fukuda, Yuichiro Ohe, Isamu Okamoto：
A treatment-related death predictive score for treatment-naïve advanced non-small cell lung cancer.
Lung cancer (Amsterdam, Netherlands)
204
：108584
, 2025
|
|
20.
|
Kenji Morimoto, Tadaaki Yamada, Naoki Furuya, Hisashi Tanaka, Akihiro Yoshimura, Tomohiro Oba, Makoto Hibino, Takahito Fukuda, Yasuhiro Goto, Akira Nakao, Shinsuke Ogusu, Yuta Okazaki, Taishi Harada, Takayo Ota, Ken Masubuchi, Koji Mikami, Tae Hata, Shoki Matsumoto, Ryoichi Honda, Koji Date, Yusuke Chihara, Hayato Kawachi, Koichi Takayama：
Impact of EGFR Mutation Subtypes on Response to Chemoimmunotherapy and Chemotherapy in Non-Small-Cell Lung Cancer After EGFR-TKI Failure.
Targeted oncology
20
(3)
：531
-541
, 2025
|
|
21.
|
Masashi Ishihara, Takahisa Kawamura, Yukiko Namba, Yuki Takeyasu, Yukihiro Hasegawa, Yuki Sato, Yoshiki Negi, Tomohiro Oba, Toshiyuki Sumi, Hirokuni Hirata, Hidemitsu Funabashi, Yuko Oya, Hajime Kikuchi, Naoko Katsurada, Takeshi Nakatani, Keiko Tanimura, Taku Nakagawa, Naoya Takeda, Takahiro Asami, Osamu Honjo, Hiromi Nagashima, Takumi Yamaura, Norihiko Hata, Miyako Kitazono, Naoya Nishioka, Akihiro Tamiya, Yuichi Sakamori, Ryota Shigaki, Kyoichi Kaira, Ryoichi Honda, Takashi Matsui, Eriko Suzuki, Kentaro Ito, Kojiro Otsuka, Naoto Takase, Yusuke Murakami, Kazuhiko Matsuno, Sumito Inoue, Akira Kisohara, Sojiro Kusumoto, Hiroe Aoshima, Yumiko Kakizaki, Akihito Kubo, Akito Hata, Nobuhisa Ishikawa, Kosuke Hamai, Nobuhiro Kanaji, Toshihiro Misumi, Noriyuki Matsutani, Nobuhiko Seki：
Ramucirumab and erlotinib combination as first-line treatment for advanced or recurrent non-small cell lung cancer harboring EGFR Exon21 L858R mutation: a multicenter retrospective observational cohort study in Japan (REAL-SPEED).
Therapeutic advances in medical oncology
17
：17588359251344010
, 2025
|
|
22.
|
Shiho Goda, Tadaaki Yamada, Kenji Morimoto, Tae Hata, Yasuhiro Goto, Akihiko Amano, Yoshiki Negi, Satoshi Watanabe, Naoki Furuya, Tomohiro Oba, Tatsuki Ikoma, Akira Nakao, Keiko Tanimura, Hirokazu Taniguchi, Akihiro Yoshimura, Tomoya Fukui, Daiki Murata, Kyoichi Kaira, Shinsuke Shiotsu, Asuka Okada, Makoto Hibino, Yusuke Chihara, Takashi Kijima, Koichi Takayama：
Impact of immune-related adverse events on clinical outcomes in patients with advanced non-small cell lung cancer with low PD-L1 expression, focusing on pneumonitis: a multicenter retrospective study in Japan.
Translational lung cancer research
14
(4)
：1185
-1196
, 2025
|
|
23.
|
Hayato Kawachi, Tae Hata, Tadaaki Yamada, Yasuhiro Goto, Akihiko Amano, Yoshiki Negi, Satoshi Watanabe, Naoki Furuya, Tomohiro Oba, Tatsuki Ikoma, Akira Nakao, Keiko Tanimura, Hirokazu Taniguchi, Akihiro Yoshimura, Tomoya Fukui, Daiki Murata, Kyoichi Kaira, Shinsuke Shiotsu, Makoto Hibino, Asuka Okada, Yusuke Chihara, Takashi Kijima, Koichi Takayama：
Outcomes of chemotherapy with or without immunotherapy in older patients with non-small cell lung cancer and low PD-L1 expression.
Translational lung cancer research
14
(5)
：1558
-1568
, 2025
|
|
総説及び解説
|
|
1.
|
藤本 一志，池田 慧：
【あらためて考える—肺癌周術期治療 課題とこれから】Ⅵ. ドライバー遺伝子変異/転座を有する非小細胞肺癌の周術期治療 EGFR遺伝子変異陽性非小細胞肺癌に対する周術期治療.
呼吸器ジャーナル
73
(1)
：101
-110
, 2025
|
|
2.
|
池田慧、立石和也、田中健介：
高度に専門化する肺がん診療にどんと構えるために チーム医療、共同意思決定、薬の選び方.
内科
153
(2)
：303
-310
, 2025
|
|
